share_log

CVS Health | 10-Q: Q1 2024 Earnings Report

CVS Health | 10-Q: Q1 2024 Earnings Report

西维斯健康 | 10-Q:2024财年一季报
美股SEC公告 ·  05/01 06:44
Moomoo AI 已提取核心信息
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
西维斯健康报告2024年第一季度营业收入下降,营业收入从去年同期的34.46亿美元下降到22.71亿美元。调整后的营业收入也同比下降,从去年的43.7亿美元降至29.57亿美元。然而,公司的总收入实现了微小的增长,达到了884.37亿美元,其中消费者健康保健和药房及消费者健康部门的增长驱动了此增长,尽管医疗保健服务部门出现下滑。归属于西维斯健康的净收入大幅下降47.9%,从21.36亿美元降至11.13亿美元。消费者健康保健部门总收入增长了24.6%,而医疗保健服务部门的收入下降了9.7%。药房及消费者健康部门的收入增长了2.9%。西维斯健康的未来计划包括扩大其新的 Cordavis、Oak Street Health 和 Signify Health 业务,并预计继续与客户分享更大部分的折扣、费用和回扣。该公司还预计实施企业范围内的持续性降低运营成本的成本节约措施和投资效率。
西维斯健康报告2024年第一季度营业收入下降,营业收入从去年同期的34.46亿美元下降到22.71亿美元。调整后的营业收入也同比下降,从去年的43.7亿美元降至29.57亿美元。然而,公司的总收入实现了微小的增长,达到了884.37亿美元,其中消费者健康保健和药房及消费者健康部门的增长驱动了此增长,尽管医疗保健服务部门出现下滑。归属于西维斯健康的净收入大幅下降47.9%,从21.36亿美元降至11.13亿美元。消费者健康保健部门总收入增长了24.6%,而医疗保健服务部门的收入下降了9.7%。药房及消费者健康部门的收入增长了2.9%。西维斯健康的未来计划包括扩大其新的 Cordavis、Oak Street Health 和 Signify Health 业务,并预计继续与客户分享更大部分的折扣、费用和回扣。该公司还预计实施企业范围内的持续性降低运营成本的成本节约措施和投资效率。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息